For Fabry Awareness Month this April, the Fabry International Network, or FIN — an alliance of 61 patient organizations…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
People with different lysosomal storage diseases have varying beliefs about prescribed medicines, which reflect their current medical needs, a study…
A Fabry disease diagnosis for a woman in Portugal came only after she had a stroke in her early…
Throughout 2024, the team at Fabry Disease News brought our readers all the latest updates on research related to …
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to EXG110, an experimental gene therapy for…
Amicus Therapeutics and Teva Pharmaceuticals have struck a deal that will allow the latter to sell a generic version…
Programs that systematically tested for Fabry disease in nearly 1,000 people with chronic pain at centers in France led…
An international team of scientists has developed a novel algorithm that may help identify people with Fabry disease based…
Despite available treatments, many people with Fabry disease still experience symptoms that can affect their quality of life, a…
People with Fabry disease have higher-than-normal levels of three inflammatory markers in their blood, according to a recent study.